Effects of aerobic training and semaglutide treatment on pancreatic β-cell secretory function in patients with type 2 diabetes.
Arthur IngersenMalte SchmückerChristina AlexandersenBenjamin GraungaardTobias ThorngreenJacob BorchJens Juul HolstJørn Wulff HelgeFlemming DelaPublished in: The Journal of clinical endocrinology and metabolism (2023)
The combination of aerobic training and semaglutide treatment synergistically improved β-cell secretory function. (ClinicalTrials.gov number, ID NCT04383197).